(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MISSION: GENOME BY ROCKET PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MISSION: GENOME BY ROCKET PHARMA

ST13

US500000098870849

Class

35, 41, 44

Filing

98870849

Registration

8156250

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

03/03/2026

Trademark type

Combined

Nice classes

35, 41, 44

Filing date

11/25/2024

Registration date

03/03/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/03/2026

Last transaction

03/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

11/16/2024

First use in commerce

11/16/2024

Drawing code

3

Owner type

99

Owner location

Zug, CH

Examiner

YAO, GRETTA

Law office

M90

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the word "MISSION" within the negative space of a deep red rectangle on the left side of a genome design in deep red, pink, turquoise green, and turquoise blue, with a pink rocket design on the right of the genome. Below the word "MISSION" is the word "GENOME" in deep red and the words "BY ROCKET PHARMA" in deep red below the genome design. The color white is background and not part of the mark.

Holders and representatives

Holders

Rocket Pharmaceuticals GmbH

Representatives

Danny Awdeh

Technical classification

Nice Classes

Class 35Class 41Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Promoting physician awareness of rare genetic diseases; compilation of patient genetic demographic and testing datahealth-related information associated with rare diseases into a computer database

Class 41

Providing education servicesonline and in-person classesseminarsworkshops in the field of genetic testingscreening; Providing education servicesonline and in-person classesseminarsworkshops in the field of rare genetic diseases; Providing education servicesonline and in-person classesseminarsworkshops in the field of benefits of early genetic testing and screening for the detection of rare genetic diseases

Class 44

Providing genetic testing and counseling assistance for medicaldiagnostic or treatment purposes relating to rare genetic diseases; Health counseling relating to rare genetic diseases; Providing websites featuring educational information in the field of genetic testing for medical purposesscreening for medical purposeshealth counseling relating to rare genetic diseases

Publications

History of USPTO decisions and trademark events.

26 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/03/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/03/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/13/2026

PUBO

PUBLISHED FOR OPPOSITION

01/13/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/07/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/11/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

12/11/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/11/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

12/11/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/11/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/30/2025

GNRT

NON-FINAL ACTION E-MAILED

10/30/2025

CNRT

NON-FINAL ACTION WRITTEN

10/30/2025

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

10/27/2025

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

09/23/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/29/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/20/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/19/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/19/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/20/2025

GNRT

NON-FINAL ACTION E-MAILED

05/20/2025

CNRT

NON-FINAL ACTION WRITTEN

05/20/2025

DOCK

ASSIGNED TO EXAMINER

05/16/2025

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/13/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/13/2025

NWAP

NEW APPLICATION ENTERED

11/25/2024

Continuous trademark protection

Get notified about every new filing that threatens MISSION: GENOME BY ROCKET PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.